IN2015DN01093A - - Google Patents

Info

Publication number
IN2015DN01093A
IN2015DN01093A IN1093DEN2015A IN2015DN01093A IN 2015DN01093 A IN2015DN01093 A IN 2015DN01093A IN 1093DEN2015 A IN1093DEN2015 A IN 1093DEN2015A IN 2015DN01093 A IN2015DN01093 A IN 2015DN01093A
Authority
IN
India
Prior art keywords
mini
granule
mini tablets
composition
tablets
Prior art date
Application number
Other languages
English (en)
Inventor
Gabriel Marinus Henricus Meesters
Ferdinand Antoine Spros
Original Assignee
Dsm Sinochem Pharm Nl Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Sinochem Pharm Nl Bv filed Critical Dsm Sinochem Pharm Nl Bv
Publication of IN2015DN01093A publication Critical patent/IN2015DN01093A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IN1093DEN2015 2012-08-28 2013-08-26 IN2015DN01093A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12182026 2012-08-28
PCT/EP2013/067599 WO2014033077A1 (en) 2012-08-28 2013-08-26 Composition comprising an antibiotic and a beta-lactamase inhibitor, wherein at| least one of them is in the form of mini-tablets

Publications (1)

Publication Number Publication Date
IN2015DN01093A true IN2015DN01093A (de) 2015-06-26

Family

ID=46963435

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1093DEN2015 IN2015DN01093A (de) 2012-08-28 2013-08-26

Country Status (5)

Country Link
US (1) US20150238425A1 (de)
EP (1) EP2890366A1 (de)
CN (1) CN104582692A (de)
IN (1) IN2015DN01093A (de)
WO (1) WO2014033077A1 (de)

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6024766B2 (ja) 1978-03-23 1985-06-14 東洋醸造株式会社 徐放性抗生物質錠
GB2176999B (en) 1985-06-22 1989-07-12 Stanley Stewart Davis Sustained release medicament
US5430037A (en) * 1988-11-25 1995-07-04 Henning Berlin Gmbh Chemie -Und Pharmawerk Oxypurinol alkali and alkalane earth salts in amorphous or crystalline form as agents for treating hyperuricaemia and gout
IT1246382B (it) 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon
US20030124187A1 (en) * 1997-02-14 2003-07-03 Smithkline Beecham Laboratoires Pharmaceutiques, Pharmaceutical formulations comprising amoxycillin and clavulanate
AU9540898A (en) * 1997-08-29 1999-03-22 Dsm N.V. Granules free of excipients
WO1999025343A1 (en) * 1997-11-17 1999-05-27 Gist-Brocades B.V. Granules comprising clavulanate and one or more excipients
US6756057B2 (en) * 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
GB0031267D0 (en) 2000-12-21 2001-01-31 Smithkline Beecham Plc Novel compositions
AU2003255874A1 (en) 2002-08-16 2004-03-03 Orchid Health Care, A Division Of Orchid Chemicals And Pharmaceuticals Ltd. Sustained release pharmaceutical composition of a cephalosporin antibiotic
EP1715852A2 (de) * 2004-01-06 2006-11-02 Panacea Biotec Ltd. Nichtzerfallende feste zusammensetzung hochdosierter wasserlöslicher arzneistoffe zur oralen anwendung
WO2005099672A1 (en) 2004-04-13 2005-10-27 Ranbaxy Laboratories Limited A modified release pharmaceutical formulation comprising amoxicillin and clavulanate
WO2006014427A1 (en) 2004-07-02 2006-02-09 Advancis Pharmaceutical Corporation Tablet for pulsed delivery
US20060099253A1 (en) * 2004-10-20 2006-05-11 Wyeth Antibiotic product formulation
WO2006092295A1 (en) * 2005-03-02 2006-09-08 Kairosmed Gmbh Oral modified release formulations containing 8-prenylnaringenin for continuous estrogen support
BRPI0608917A2 (pt) 2005-04-12 2017-07-11 Elan Pharma Int Ltd Composição de liberação controlada de antibiótico, e, método para o tratamento de infecção bacteriana
MX2007014363A (es) 2005-05-16 2009-04-15 Elan Pharma Int Ltd Composiciones de liberacion controlada y en forma de nanoparticulas que comprenden una cefalosporina.
WO2007059916A2 (en) 2005-11-23 2007-05-31 Sandoz Ag Pharmaceutical composition
DE102006007830A1 (de) * 2006-02-17 2007-08-30 Grünenthal GmbH Lagerstabile orale Darreichungsform von Amoxicillin und Clavulansäure
WO2007106957A1 (en) 2006-03-21 2007-09-27 Laboratoires Smb S.A. Multiple units controlled-release floating dosage forms
ZA200807943B (en) * 2006-03-24 2009-11-25 Panacea Biotec Ltd Antibiotic compositions of modified release and process of production thereof
US20090285887A1 (en) 2006-09-12 2009-11-19 Omar Abdelfattah Abu-Baker Pharmaceutical Composition Comprising A Plurality of Mini-Tablets Comprising A Factor XA Inhibitor
CA2677623C (en) * 2007-02-09 2015-04-07 Alphapharm Pty Ltd A dosage form containing two or more active pharmaceutical ingredients in different physical forms
US20120027855A1 (en) 2007-07-06 2012-02-02 Lupin Limited Pharmaceutical compositions for gastrointestinal drug delivery
ES2798253T3 (es) 2007-07-06 2020-12-10 Lupin Ltd Composiciones farmacéuticas de rifaximina
US20120003312A1 (en) 2010-06-30 2012-01-05 Aptapharma, Inc. Multilayer Minitablets with Different Release Rates

Also Published As

Publication number Publication date
EP2890366A1 (de) 2015-07-08
US20150238425A1 (en) 2015-08-27
WO2014033077A1 (en) 2014-03-06
CN104582692A (zh) 2015-04-29

Similar Documents

Publication Publication Date Title
IL231203A (en) Selective and reversible inhibitors of ubiquitin-specific Protease 7, their pharmaceutical preparations and therapeutic applications
IL232113A (en) Boron-containing compounds, pharmaceuticals containing them and their use in inhibiting arginase
MX338515B (es) Derivados de tetrahidroquinolina utiles como inhibidores de bromodominio.
IL232038A (en) Nephrilicin-inhibiting compounds containing oxalil, a process for obtaining them, and pharmaceuticals containing them
PT2938362T (pt) Processo de granulação por via seca para produzir composições de comprimidos de metformina e composições associadas
IN2015DN03795A (de)
MX2014011825A (es) INHIBIDORES DE ISOXAZOL ß-LACTAMASA.
EP2542514A4 (de) Düngemittelzusammensetzung mit mikronährstoffen und herstellungsverfahren dafür
IL220863A (en) Oxazole derivatives of kinase inhibitors, medicinal preparations containing them and their uses
IL237321A0 (en) ddr2 inhibitors and pharmaceutical preparations containing them
IL222771A (en) Manufacture of granules without active substance and tablets containing them
HUE044300T2 (hu) 3-amino-cikloalkil-vegyületek, mint ROR-GAMMA-T inhibitorok és alkalmazásuk
IL237322A0 (en) Solid pharmaceutical preparations containing levothyroxine and their preparation
MX353061B (es) Nuevos comprimidos de meloxicam de baja concentracion.
EP2626071A4 (de) Anwendungen von arctigenin zur formulierung von arzneimitteln zur prophylaxe oder behandlung von erkrankungen im zusammenhang mit der reduzierung roter blutkörperchen
PT3071218T (pt) Composição farmacêutica contendo uma mistura de proenzimas e enzimas
GEP201706675B (en) Imidazo-triazine derivatives as pde10 inhibitors
IL227024A (en) The 3 heteroarylamino propionic acid derivatives are converted into amino acids, a process for their preparation, their use in the preparation of medicinal preparations and as medical preparations containing them
TR201009167A2 (tr) Sefalosporin içeren farmasötik granüller.
IN2013MU02911A (de)
HUP1600414A2 (hu) Bisoprololt és ramiprilt tartalmazó stabil kombinációs gyógyszerkészítmény
MX356373B (es) Composiciones que comprenden un agente antibacterial y tazobactam.
PH12013500468A1 (en) Granules
NZ715615A (en) Pharmaceutical compositions of ranolazine and dronedarone
TR201011148A1 (tr) Levetirasetam farmasötik bileşimleri.